Thomas P. Hackett MD Endowed Chair in Psychiatry, Massachusetts General Hospital
Director, Dauten Family Center for Bipolar Treatment Innovation
Associate Director, Depression Clinical and Research Program
Co-Director, Center for Clinical Research Education, Division of Clinical Research
Professor of Psychiatry, Harvard Medical School
Dr. Andrew Nierenberg graduated from the Albert Einstein College of Medicine of Yeshiva University, Bronx, NY. After completing his residency in psychiatry at New York University/Bellevue Hospital, he studied clinical epidemiology at Yale University as a Robert Wood Johnson Clinical Scholar. Dr. Nierenberg then joined the faculty at Harvard Medical School, first at McLean Hospital in Belmont, Massachusetts, and then at Massachusetts General Hospital. He is also an Honorary Professor in the School of Medicine, Faculty of Health at Deakin University, Geelong, Australia (where he served as a Thinker in Residence), and an Honorary Skou Professor at Aarhus University in Denmark.
Dr. Nierenberg has published over 570 papers and has been listed in The Best Doctors in America for the treatment of mood and anxiety disorders in every edition since 1994. In 2000, he was awarded the Gerald L. Klerman Young Investigator Award, and in 2014 the Gerald L. Klerman Senior Investigator Award by the Depression Bipolar Support Alliance. In 2013, Dr. Nierenberg was awarded the prestigious Brain and Behavior Research Foundation Colvin Prize for outstanding achievement in mood disorders research. In 2014, he was awarded the Mentorship Award for Exceptional Mentorship in the Research Arena at MGH. In 2014, 2015, 2016, and 2017, he was listed among the World’s Most Influential Scientific Minds by Clarivate in recognition of ranking among the top 1% of researchers for most cited papers in psychiatry worldwide, currently with over 30,000 citations and an h-factor > 90. In 2020, Dr. Nierenberg was given the International Society of Bipolar Disorder Mogen Schou Research Award, the highest award given by ISBD, and in 2021, he was elected as the vice president for research of the ISBD.
He established the Dauten Family Center for Bipolar Treatment Innovation at MGH in 2017, which has an endowment to focus on finding better treatments to get better outcomes.
Dr. Nierenberg’s primary interests are improving the use of existing treatments and finding innovative treatments for bipolar disorder. He lectures extensively, both nationally and internationally, teaches, supervises, maintains an active clinical practice, consults with industry, and conducts clinical trials funded by federal, foundation, industry, and philanthropic sources. He serves as a peer reviewer for over 35 psychiatric journals. He is a member of the editorial boards of over 15 journals, including the Journal of Clinical Psychiatry, Journal of Clinical Psychopharmacology, Journal of Affective Disorders, Australian New Zealand Journal of Psychiatry, and Bipolar Disorders. Dr. Nierenberg is a past deputy editor of Depression and Anxiety and editor of Psychiatric Annals.